New England Securities’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$60K Buy
926
+2
+0.2% +$129 0.02% 556
2014
Q3
$56K Buy
924
+2
+0.2% +$131 0.02% 588
2014
Q2
$64K Buy
922
+2
+0.2% +$130 0.02% 548
2014
Q1
$60K Buy
920
+302
+49% +$19.7K 0.02% 510
2013
Q4
$38K Sell
618
-496
-45% -$28.7K 0.02% 623
2013
Q3
$60K Sell
1,114
-441
-28% -$22.7K 0.03% 458
2013
Q2
$71K Buy
+1,555
New +$67.4K 0.05% 356

Other funds holding STJ

New England Securities's STJ Position: Q4 2014 in Review

New England Securities increased its St Jude Medical (STJ) stake by 0.22% in Q4 2014, buying an estimated $129 and bringing the position to 926 shares worth $60K. The position accounts for 0.02% of the portfolio, ranked #556.

New England Securities first reported a position in STJ in Q2 2013 and has held it in 7 quarters since. The position peaked at $71K in Q2 2013. 591 funds tracked by Wall St. Rank hold STJ as of Q4 2014.

  • New England Securities held 926 shares of St Jude Medical worth $60K as of Q4 2014.
  • New England Securities bought 2 St Jude Medical shares in Q4 2014, an estimated $129.
  • St Jude Medical made up 0.02% of New England Securities's portfolio in Q4 2014, its #556 holding.
  • New England Securities first reported a position in St Jude Medical in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's St Jude Medical position peaked at $71K in Q2 2013.
  • 591 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.